The family that brought OxyCotin to market has agreed to a $7.4 billion nationwide settlement, and Utah is poised to get a ...

Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

The deal represents an increase over a previous settlement rejected by the Supreme Court because it protected members of the ...

Pennsylvania stands to receive up to $212 million paid out by the family and firm behind the nationwide saturation of OxyContin as part of the latest legal settlement ...

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not ...

Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of U.S. states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid ...

A $7.4 billion settlement has been reached with Purdue Pharma, marking a major victory in the battle against the opioid ...

The new settlement deal could net Pennsylvania and Delaware as much as $212 million and $27 million, respectively, in payouts.

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...